sb 203580 has been researched along with 1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea) | Trials (1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea) | Recent Studies (post-2010) (1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 13 | 0 | 1 |
| Protein | Taxonomy | sb 203580 (IC50) | 1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.7943 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitfelder, S; Cirillo, P; Gilmore, T; Graham, AG; Hickey, E; Klaus, B; Madwed, J; Moriak, M; Moss, N; Pargellis, C; Pav, S; Proto, A; Regan, J; Swinamer, A; Tong, L; Torcellini, C | 1 |
1 other study(ies) available for sb 203580 and 1-(3-tert-butyl-1-methylpyrazol-5-yl)-3-(4-chlorophenyl)urea
| Article | Year |
|---|---|
Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Cell Line; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Enzyme Inhibitors; Female; Fluorescence; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Models, Molecular; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Protein Binding; Pyrazoles; Structure-Activity Relationship; Tumor Necrosis Factor-alpha; Urea | 2002 |